← Leaderboards
Thomas Michael Raffay
Case Western Reserve University
$2,146,362
Attributed
$2,146,362
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $592.3K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,146,362 · 3
By mechanism
R01$1,184,606 · 1
K08$821,444 · 1
R03$140,312 · 1
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Jonathan S. Stamler$32,849,627
- Richard J. Martin$10,465,557
- David M. Katz$8,572,425
- Sixto Manuel Leal$18,721,660
- Mitchell L Drumm$12,943,746
Others in their field
Other Emerging Leaders on “S-Nitrosoglutathione”
- Ling Yang · University Of Iowa$3,485,837
- Alexander Keith Wolf · Nota Laboratories, Llc$1,730,175
- Joan A Keiser · Nota Laboratories, Llc$752,354
- Jeseong Won · Medical University Of South Carolina$413,927
- Jonathan Edward McDunn · Clinical Sensors, Inc.$215,501
- Kelsey Shea Kalous · Medical College Of Wisconsin$109,664
Research focus
S-NitrosoglutathionePreventPhenotypeOxygenPremature InfantComplicationEnzymesIncidenceMicrornasOxidoreductasePremature BirthChronicBronchopulmonary DysplasiaAnimal ModelAdultCatabolismHyperoxiaBreathingAirway HyperresponsivenessLungAttenuatedNeonatalCostS-Nitrosothiols
Grant awards (9)
S-Nitrosoglutathione therapy for oxidant disease of the neonatal airways and lung$592,303
R01 · FY2025 · HL · contact PI
S-Nitrosoglutathione therapy for oxidant disease of the neonatal airways and lung$592,303
R01 · FY2024 · HL · contact PI
Pilot Study of an Inhaled Treatment for Bronchopulmonary Dysplasia$68,244
R03 · FY2022 · HL · contact PI
S-nitrosoglutathione reductase and airways hyperreactivity in murine bronchopulmonary dysplasia$163,603
K08 · FY2021 · HL · contact PI
Pilot Study of an Inhaled Treatment for Bronchopulmonary Dysplasia$72,068
R03 · FY2021 · HL · contact PI
S-nitrosoglutathione reductase and airways hyperreactivity in murine bronchopulmonary dysplasia$164,152
K08 · FY2020 · HL · contact PI
S-nitrosoglutathione reductase and airways hyperreactivity in murine bronchopulmonary dysplasia$164,289
K08 · FY2019 · HL · contact PI
S-nitrosoglutathione reductase and airways hyperreactivity in murine bronchopulmonary dysplasia$164,700
K08 · FY2018 · HL · contact PI
S-nitrosoglutathione reductase and airways hyperreactivity in murine bronchopulmonary dysplasia$164,700
K08 · FY2017 · HL · contact PI